Skip to main content

Acamprosate Calcium Tablets Shortage

Last Updated: August 3, 2025
Status: Current

Products Affected - Description
    • Acamprosate calcium oral tablet, Glenmark, 333 mg, bottle, 180 count, NDC 68462-0435-18
    • Acamprosate calcium oral tablet, Zydus, 333 mg, bottle, 180 count, NDC 68382-0569-28
Reason for the Shortage
    • Glenmark did not provide a reason for the shortage.
    • Viatris has acamprosate tablets available.
    • Zydus did not provide a reason for the shortage.
Available Products
    • Acamprosate calcium oral tablet, Mylan (Viatris), 333 mg, bottle, 180 count, NDC 00378-6333-80

Estimated Resupply Dates

    • Glenmark has acamprosate 333 mg tablets on intermittent back order and the company is releasing supplies as they become available.
    • Zydus has acamprosate 333 mg tablets on allocation.

Updated

Updated August 3, 2025 by Elyse MacDonald, PharmD, MS, BCPS. Created September 30, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer